Although IFN-γ-stimulated B cells of MS patients show enhanced pro-inflammatory capacity (44, 48), it is unclear whether alterations in the IFN-γ signaling pathway contribute to the development of T-bet+ B cells infiltrating the CNS. This evidence concerns the gene IFNG and myeloid sarcoma.